ONCOLYTICS BIOTECH INC (ONCY) › Cash & EquivalentsONCOLYTICS BIOTECH INC (ONCY) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $11.08M2025: $5.20M$5.20M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$5.20M-53.0%2024$11.08M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share